Investors Relations
Delivering nature's goodness to everyone.
By Year : Latest | All |
2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008
- 22Mar 23 Change - Announcement Of Appointment Of Non-Independent Non-Executive Director
- 22Mar 23 Change - Announcement Of Appointment Of Executive Director And Strategy Director
- 22Mar 23 Change - Announcement Of Resignation Of Non-Independent And Non-Executive Director
- 22Mar 23 Change - Announcement Of Resignation Of Non-Independent And Non-Executive Director
- 01Mar 23 Updates To Shareholders
- 01Mar 23 Responses To SGX Queries On The Company's Unaudited Interim Financial Statement For The Financial Period Ended 31 December 2022
- 18Feb 23 Proposed Placement Of 125,000,000 New Ordinary Shares In The Capital Of Sunmoon Food Company Limited At The Placement Price Of S$0.023 Per Share For An Aggregate Consideration Of S$2,875,000
- 18Feb 23 Proposed Placement Of 125,000,000 New Ordinary Shares In The Capital Of Sunmoon Food Company Limited At The Placement Price Of S$0.0280 Per Share For An Aggregate Consideration Of S$3,500,000 - Lapse Of Long-Stop Date
- 09Feb 23 Financial Statements And Related Announcement - Third Quarter Results
- 31Jan 23 Monthly Valuation Of Assets And Utilisation Of Cash For The Month Of December 2022
- 13Jan 23 Increase Of Registered Share Capital Of Subsidiary
- 13Jan 23 Updates To Shareholders
- 30Dec 22 Updates To Shareholders
- 22Dec 22 Monthly Valuation Of Assets And Utilisation Of Cash For The Month Of November 2022
- 28Nov 22 Appointment Of Director And Changes In The Composition Of The Board Of Directors
- 28Nov 22 Change - Announcement Of Appointment Of Independent Non-Executive Director
- 23Nov 22 Monthly Valuation Of Assets And Utilisation Of Cash For The Month Of October 2022
- 11Nov 22 Update To Shareholders On The Completion Of The Bankruptcy Reorganisation
- 03Nov 22 Incorporation Of A Joint Venture Company
- 03Nov 22 Financial Statements And Related Announcement - Second Quarter And/ Or Half Yearly Results